 | Up a level |
Gensicke, H; Wicht, A; Bill, O; Zini, A; Costa, P; Kägi, G; Stark, R; Seiffge, D J; Traenka, C; Peters, N; Bonati, L H; Giovannini, G; De Marchis, G M; Poli, L; Polymeris, A; Vanacker, P; Sarikaya, Hakan; Lyrer, P A; Pezzini, A; Vandelli, L; ... (2016). Impact of body mass index on outcome in stroke patients treated with intravenous thrombolysis. European journal of neurology, 23(12), pp. 1705-1712. Wiley-Blackwell 10.1111/ene.13071
Konrad, A; Lehrke, M; Schachinger, V; Seibold, F; Stark, R; Ochsenkühn, T; Parhofer, K; Göke, B; Broedl, U (2007). Resistin is an inflammatory marker of inflammatory bowel disease in humans. European journal of gastroenterology & hepatology, 19(12), pp. 1070-1074. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MEG.0b013e3282f16251
Lehrke, M; Konrad, A; Schachinger, V; Tillack, C; Seibold, F; Stark, R; Parhofer, KG; Broedl, UC (2007). CXCL 16 is a surrogate marker of inflammatory bowel disease. Scandinavian journal of gastroenterology, 43(3), pp. 283-288. London: Informa Healthcare 10.1080/00365520701679249
Broedl, UC; Schachinger, V; Lingenhel, A; Lehrke, M; Stark, R; Seibold, F; Goke, B; Kronenberg, F; Parhofer, KG; Konrad-Zerna, A (2006). Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease. Inflammatory bowel diseases, 13(4), pp. 391-397. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20078
Ambach, W; Stark, R; Vaitl, D; Peper, M (2006). Processes involved in lying: separating lying and recognition in a Guilty Knowledge Test with polygraph recordings. Annual Meeting of the DGPA. Journal of psychophysiology(20), p. 115. Göttingen: Hogrefe & Huber
